Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 2326 AL 2340

Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality

Hwang J, Adamson C, Butler D, Janero DR, Makriyannis A, Bahr BA.

Life Sci. 2010 Apr 10;86(15-16):615-23. doi: 10.1016/j.lfs.2009.06.003. Epub 2009 Jun 13.

[Shared psychotic disorder (Folie à deux) and Huntington's disease]

Roth C, Stüwe R, Böger A, Serafin S, Franz M.

Psychiatr Prax. 2010 Jan;37(1):43-5. doi: 10.1055/s-0029-1220338. Epub 2009 Jun 29.

Systemic transplantation of mesenchymal stem cells can reduce cognitive and motor deficits in rats with unilateral lesions of the neostriatum

Edalatmanesh MA, Matin MM, Neshati Z, Bahrami AR, Kheirabadi M.

Neurol Res. 2010 Mar;32(2):166-72. doi: 10.1179/174313209X409025. Epub 2009 Jun 30.

Impaired mitochondrial trafficking in Huntington's disease

Li XJ, Orr AL, Li S.

Biochim Biophys Acta. 2010 Jan;1802(1):62-5. doi: 10.1016/j.bbadis.2009.06.008. Epub 2009 Jul 8.

The antiphospholipid syndrome as a neurological disease

Arnson Y, Shoenfeld Y, Alon E, Amital H.

Semin Arthritis Rheum. 2010 Oct;40(2):97-108. doi: 10.1016/j.semarthrit.2009.05.001. Epub 2009 Jul 12.

[Locomotion disturbances in Huntington's disease]

Delval A, Krystkowiak P.

Rev Neurol (Paris). 2010 Feb;166(2):213-20. doi: 10.1016/j.neurol.2009.05.013. Epub 2009 Jul 14.

Mitochondria in Huntington's disease

Damiano M, Galvan L, Déglon N, Brouillet E.

Biochim Biophys Acta. 2010 Jan;1802(1):52-61. doi: 10.1016/j.bbadis.2009.07.012. Epub 2009 Aug 11.

Downstream mechanisms triggered by mitochondrial dysfunction in the basal ganglia: from experimental models to neurodegenerative diseases

Gubellini P, Picconi B, Di Filippo M, Calabresi P.

Biochim Biophys Acta. 2010 Jan;1802(1):151-61. doi: 10.1016/j.bbadis.2009.08.001. Epub 2009 Aug 14.

Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases

Gibson GE, Starkov A, Blass JP, Ratan RR, Beal MF.

Biochim Biophys Acta. 2010 Jan;1802(1):122-34. doi: 10.1016/j.bbadis.2009.08.010. Epub 2009 Aug 26.

Multifaceted deaths orchestrated by mitochondria in neurones

Nagley P, Higgins GC, Atkin JD, Beart PM.

Biochim Biophys Acta. 2010 Jan;1802(1):167-85. doi: 10.1016/j.bbadis.2009.09.004. Epub 2009 Sep 12.

Prion protein and metal interaction: physiological and pathological implications

Singh N, Das D, Singh A, Mohan ML.

Curr Issues Mol Biol. 2010;12(2):99-107. Epub 2009 Sep 18.

Structure and function of the molecular chaperone Hsp104 from yeast

Grimminger-Marquardt V, Lashuel HA.

Biopolymers. 2010 Mar;93(3):252-76. doi: 10.1002/bip.21301.

Hsp70 molecular chaperones and Parkinson's disease

Witt SN.

Biopolymers. 2010 Mar;93(3):218-28. doi: 10.1002/bip.21302.

3-nitropropionic acid-induced mitochondrial permeability transition: comparative study of mitochondria from different tissues and brain regions

Mirandola SR, Melo DR, Saito A, Castilho RF.

J Neurosci Res. 2010 Feb 15;88(3):630-9. doi: 10.1002/jnr.22239.

Bilateral deep brain stimulation for treatment of medically refractory paroxysmal nonkinesigenic dyskinesia

Kaufman CB, Mink JW, Schwalb JM.

J Neurosurg. 2010 Apr;112(4):847-50. doi: 10.3171/2009.9.JNS09454.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias